Advertisement

Topics

Aquila BioMedical, Macrophage Pharma Extend Immuno-Oncology Agreement

04:21 EST 10 Nov 2017 | Contract Pharma

The partnership will help generate data to choose the best preclinical candidate for investigational new drug selection

Original Article: Aquila BioMedical, Macrophage Pharma Extend Immuno-Oncology Agreement

NEXT ARTICLE

More From BioPortfolio on "Aquila BioMedical, Macrophage Pharma Extend Immuno-Oncology Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...